Upon binding, inh‐2 stabilizes CFTR, preventing RNF5 from recognizing and ubiquitylating it, and has shown promising anti‐tumor activity in preclinical studies by inhibiting tumor growth and promoting apoptosis in various cancer models. Here, RNF5 is linked to neoplasm.